Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare Q2 revenue rises 5.7% to $5.3 billion; reaffirms 2026 guidance

Positive Impact 3 of 5 earnings Written later

GE HealthCare reported second quarter 2026 revenue of $5.3 billion, up 5.7%, and net income attributable to the company of $561 million, up from $486 million a year earlier. Results were helped by $129 million of net income from IEEPA tariff refunds, and the company reaffirmed its full-year 2026 guidance, though its Patient Care Solutions segment declined and the company is reviewing strategic options for that business.

Key points

  • Diluted EPS was $1.24 versus $1.06, and adjusted EPS was $1.13 versus $1.06, with both measures benefiting from tariff refunds and a lower tax rate.
  • Adjusted EBIT margin was 14.2% versus 14.6%, down 40 basis points, and Patient Care Solutions revenue fell 13.3% to $675 million with a segment EBIT loss of $26 million.
  • Total orders rose 11.1% organically, with backlog of $23.9 billion at June 30, 2026.
  • The company repurchased 3.3 million shares for $200 million and declared a quarterly dividend of $0.035 per share, and it reaffirmed full-year adjusted EPS guidance of $4.80 to $5.00.

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECJul 29, 2026, 6:25 AM ET
Accession number0001932393-26-000045

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.